Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by kristian7on Jul 11, 2018 11:40pm
461 Views
Post# 28303988

RE:RE:something is up ?

RE:RE:something is up ? Nicely orchestrated by US firms to take their position, since Pg delay end of March...  they got in the stock before Nasdaq listing. Train will be back on rails right after the announcement of a 4050 global deal and SP will gain back petty quickly $2+ and $3+ right after Pg approval ... Then will come Nasdaq , to reach fair market value near 4-5 billions market cap to compare with Fibrinogen and Galapagos . Decent return after all , especially if all this is set over the next 12 months !!!
Bullboard Posts